Spero Therapeutics SPRO
NASDAQ SPRO
$1.15 -0.01 (-1.28%)
As of: Oct 22, 2026 · 10:49 AM EDT

Spero Therapeutics (SPRO) Return on Assets [ROA] (2017 - 2026)

Updated

Spero Therapeutics (SPRO) recorded Return on Assets [ROA] of 13.23% in Q2 2026, up 89.96 percentage points from -76.73% a year earlier but down 10.60 percentage points from the prior quarter.

Analysis

Spero Therapeutics (SPRO) Return on Assets [ROA] (2017 - 2026) Analysis & Trends

For FY2025, Spero Therapeutics reported Return on Assets [ROA] of 9.58%, up 56.42 percentage points from FY2024.

  • Annual Return on Assets [ROA] has a five-year change of +69.90 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -46.84% in FY2024 (-61.68 pp), 14.85% in FY2023 (+46.22 pp), -31.37% in FY2022 (+23.97 pp) and -55.34% in FY2021 (+4.98 pp).
  • Quarterly Return on Assets [ROA] has ranged from -159.98% in Q3 2022 to 23.83% in Q1 2026 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased for three consecutive quarters, with an average year-over-year change of -7.88 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 158.41 percentage points in Q3 2023, against a drop of 100.12 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 23.83% (Q1 2026), 13.89% (Q4 2025) and -75.50% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,162.99 Bn 1,131.58 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 633.71 Bn 552.23 Bn 17.26 Bn 10.47%
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn 4.65%
4 Merck 376.48 Bn 330.86 Bn 12.21 Bn 2.45%
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn 10.60%
6 Astrazeneca 267.02 Bn 240.70 Bn 12.86 Bn 9.10%
7 Amgen 240.85 Bn 196.25 Bn 7.24 Bn 9.29%
8 Gilead Sciences 193.39 Bn 167.58 Bn 6.22 Bn -6.13%
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn 2.14%
10 Spero Therapeutics 67.24 Mn -128.54 Mn - 13.23%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.23%
Mar 31, 2026 23.83%
Dec 31, 2025 13.89%
Sep 30, 2025 -75.50%
Jun 30, 2025 -76.73%
Mar 31, 2025 -74.21%
Dec 31, 2024 -55.88%
Sep 30, 2024 2.43%
Jun 30, 2024 10.96%
Mar 31, 2024 13.36%
Dec 31, 2023 15.77%
Sep 30, 2023 -1.57%
Jun 30, 2023 -9.54%
Mar 31, 2023 -22.63%
Dec 31, 2022 -49.04%
Sep 30, 2022 -159.98%
Jun 30, 2022 -108.20%
Mar 31, 2022 -65.13%
Dec 31, 2021 -56.88%
Sep 30, 2021 -59.86%
API Access

Spero Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SPRO&period=max&api_key=YOUR_API_KEY